Cargando…

Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A

Expression of OCT4A is one of the hallmarks of pluripotency, defined as a stem cell’s ability to differentiate into all the lineages of the three germ layers. Despite being defined as non-tumorigenic cells with high translational potential, human mid-trimester amniotic fluid stem cells (hAFSCs) are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vlahova, Filipa, Hawkins, Kate E., Ranzoni, Anna Maria, Hau, Kwan-Leong, Sagar, Rachel, Coppi, Paolo De, David, Anna L., Adjaye, James, Guillot, Pascale V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544653/ https://www.ncbi.nlm.nih.gov/pubmed/31148575 http://dx.doi.org/10.1038/s41598-019-44572-x

Ejemplares similares

Publisher Correction: Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A
por: Vlahova, Filipa, et al.
Publicado: (2020)

TGFβ-induced osteogenic potential of human amniotic fluid stem cells via CD73-generated adenosine production
por: Hau, Kwan-Leong, et al.
Publicado: (2017)

Embryonic Stem Cell‐Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic‐Ischemic Mouse Brain
por: Hawkins, Kate E., et al.
Publicado: (2018)

Counteracting bone fragility with human amniotic mesenchymal stem cells
por: Ranzoni, Anna M., et al.
Publicado: (2016)

Neuroprotection of the hypoxic-ischemic mouse brain by human CD117(+)CD90(+)CD105(+) amniotic fluid stem cells
por: Corcelli, Michelangelo, et al.
Publicado: (2018)

Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach
por: Moschidou, Dafni, et al.
Publicado: (2012)

Indomethacin for treatment of prolapsed amniotic sac “hourglass membranes” presented at late mid-trimester
por: Al-Jefout, Moamar I., et al.
Publicado: (2016)

Mid-trimester amniotic fluid proteome’s association with spontaneous preterm delivery and gestational duration
por: Hallingström, Maria, et al.
Publicado: (2020)

In utero therapy for congenital disorders using amniotic fluid stem cells
por: Ramachandra, Durrgah L., et al.
Publicado: (2014)

Proteomic biomarkers in mid-trimester amniotic fluid associated with adverse pregnancy outcomes in patients with systemic lupus erythematosus
por: Jeon, Hae Sun, et al.
Publicado: (2020)

Corrigendum: In utero therapy for congenital disorders using amniotic fluid stem cells
por: Ramachandra, Durrgah L., et al.
Publicado: (2015)

Proteomic Analysis of Early Mid-Trimester Amniotic Fluid Does Not Predict Spontaneous Preterm Delivery
por: Hallingström, Maria, et al.
Publicado: (2016)

Comparison of Bacterial DNA Profiles in Mid-Trimester Amniotic Fluid Samples From Preterm and Term Deliveries
por: Stinson, Lisa, et al.
Publicado: (2020)

Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia
por: Schiavo, Andrea Alex, et al.
Publicado: (2015)

Micro-computed tomography reconstructions of tibiae of stem cell transplanted osteogenesis imperfecta mice
por: Ranzoni, Anna M., et al.
Publicado: (2018)

Functional analysis of cell-free RNA using mid-trimester amniotic fluid supernatant in pregnancy with the fetal growth restriction
por: Cho, Hee Young, et al.
Publicado: (2018)

Association between the Concentrations of Essential and Toxic Elements in Mid-Trimester Amniotic Fluid and Fetal Chromosomal Abnormalities in Pregnant Polish Women
por: Suliburska, Joanna, et al.
Publicado: (2022)

The presence of human mesenchymal stem cells of renal origin in amniotic fluid increases with gestational time
por: Rahman, Md Shaifur, et al.
Publicado: (2018)

Amniotic Fluid Embolism After First-Trimester Abortion
por: Panda, Subrat, et al.
Publicado: (2022)

Ontological Differences in First Compared to Third Trimester Human Fetal Placental Chorionic Stem Cells
por: Jones, Gemma N., et al.
Publicado: (2012)

Study on amniotic fluid metabolism in the second trimester of Trisomy 21
por: Liu, Xiaoting, et al.
Publicado: (2019)

Mid-Second Trimester Measurement of Nasal Bone Length in North Indian Population
por: Jain, Shreshtha, et al.
Publicado: (2019)

Gatekeeper of pluripotency: A common Oct4 transcriptional network operates in mouse eggs and embryonic stem cells
por: Zuccotti, Maurizio, et al.
Publicado: (2011)

Skeletal Defect at Mid-Trimester Ultrasound Scan
por: Brandão, Pedro, et al.
Publicado: (2018)

Skeletal Defect at Mid-trimester Ultrasound Scan
por: Brandão, Pedro, et al.
Publicado: (2018)

Protein Concentrations of Thrombospondin-1, MIP-1β, and S100A8 Suggest the Reflection of a Pregnancy Clock in Mid-Trimester Amniotic Fluid
por: Viklund, Felicia, et al.
Publicado: (2020)

Magnesium concentration in amniotic fluid in the early weeks of the second trimester of pregnancy
por: Bocos Terraz, Julia Pilar, et al.
Publicado: (2011)

OCT4: A penetrant pluripotency inducer
por: Wang, Xuecong, et al.
Publicado: (2014)

Vasa praevia: ultrasound diagnosis at the mid‐trimester scan
por: Marr, Stefanie, et al.
Publicado: (2015)

The role of mid-trimester ultrasound scan: scope and limitations
Publicado: (2023)

Urocortin in Second Trimester Amniotic Fluid: Its Role as Predictor of Preterm Labor
por: Iavazzo, C., et al.
Publicado: (2009)

Amniotic Sac Herniation Through a Prior Cornual Scar in The Third Trimester
por: Saad, Antonio F., et al.
Publicado: (2015)

Second‐trimester amniotic fluid proteins changes in subsequent spontaneous preterm birth
por: Marcellin, Louis, et al.
Publicado: (2023)

MASTL is enriched in cancerous and pluripotent stem cells and influences OCT1/OCT4 levels
por: Närvä, Elisa, et al.
Publicado: (2022)

Expression of the Pluripotency Transcription Factor OCT4 in the Normal and Aberrant Mammary Gland
por: Hassiotou, Foteini, et al.
Publicado: (2013)

Antiphospholipid Antibodies in Iraqi Women with Recurrent Mid-Trimester Abortions
por: Al Samarrai, Amel AA, et al.
Publicado: (2012)

Mid-trimester cesarean scar pregnancy: a case report
por: Fowler, Mary Louise, et al.
Publicado: (2021)

No SARS-CoV-2 detected in amniotic fluid in mid-pregnancy
por: Yu, Nan, et al.
Publicado: (2020)

Role of Oct4 in maintaining and regaining stem cell pluripotency
por: Shi, Guilai, et al.
Publicado: (2010)

Transcriptional Activation by Oct4 Is Sufficient for the Maintenance and Induction of Pluripotency
por: Hammachi, Fella, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7rtk97nj909sja6nbru0n5n6es